Geffon 250 mg Tablet

उत्पाद विवरण

Geffon 250 mg Tablet is an effective treatment option for adults diagnosed with non-small cell lung cancer (NSCLC) that has metastasized, particularly in patients whose tumors exhibit mutations in the EGFR gene and who have not undergone prior cancer therapies. This targeted therapy works by inhibiting the activity of the abnormal EGFR protein, which plays a crucial role in the growth and spread of cancer cells, thereby helping to slow disease progression. It is important to note that Geffon 250 mg is not recommended for children or adolescents, as its safety and efficacy have not been established in these populations. Patients using this medication should be aware of potential side effects, including skin rashes and gastrointestinal issues, and must consult their healthcare provider for personalized advice and monitoring. As with any cancer treatment, regular follow-ups are essential to assess the drug's effectiveness and manage any adverse reactions. By offering a focused approach to cancer care, Geffon 250 mg Tablet aims to improve the quality of life for those affected by advanced NSCLC. Always discuss your treatment options with a qualified healthcare professional to ensure that Geffon is suitable for your specific medical condition.